World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
17703
World Ranking
2586
National Ranking
1043

William C. Olson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where William C. Olson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 183 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

William C. Olson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where William C. Olson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

William C. Olson is affiliated with Regeneron in the United States, focusing on research that spans medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their work primarily addresses the fields of oncology, immunology, molecular biology, radiology, nuclear medicine and imaging, as well as biomedical engineering.

The scientist's publications concentrate on topics related to monoclonal and polyclonal antibodies research, CAR-T cell therapy research, immunotherapy and immune responses, cancer immunotherapy and biomarkers, immune cell function and interaction, cytokine signaling pathways and interactions, and the complement system in diseases.

Among Olson's recent papers are the following:

  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail, 2020, Science
  • A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies, 2020, Science Translational Medicine
  • Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning, 2021, Scientific Reports
  • Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy, 2020, Science Translational Medicine
  • Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response, 2021, Journal of Allergy and Clinical Immunology

Frequent co-authors who have collaborated with Olson include:

  • Matthew C. Franklin
  • Andrew Murphy
  • Tammy Huang
  • George D. Yancopoulos
  • Ashique Rafique

Olson's research has been published predominantly in various venues, with the most frequent publication outlets listed as:

  • Science Translational Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Cancer Therapeutics
  • Cancer Research
  • Nature Communications

Best Publications

  • CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

    Alexandra Trkola;Tatjana Dragic;James Arthos;James M. Binley

  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

    Johanna Hansen;Alina Baum;Kristen E. Pascal;Vincenzo Russo

  • A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

    Robert Pejchal;Katie J. Doores;Katie J. Doores;Laura M. Walker;Reza Khayat

  • A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

    James M. Binley;Rogier W. Sanders;Brian Clas;Norbert Schuelke

  • A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

    Noura S. Abul-Husn;Xiping Cheng;Alexander H. Li;Yurong Xin

  • Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1

    Rogier W. Sanders;Mika Vesanen;Norbert Schuelke;Aditi Master

  • L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.

    Jason P. Gardner;Robert J. Durso;Robert R. Arrigale;Gerald P. Donovan

  • Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120

    Maxime Moulard;Hugues Lortat-Jacob;Isabelle Mondor;Guillaume Roca

  • The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy

    Norbert Schülke;Olga A. Varlamova;Gerald P. Donovan;Dangshe Ma

  • Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140

    Alexandra Trkola;Thomas J. Ketas;Kirsten A. Nagashima;Lu Zhao

  • Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

    William C. Olson;Gwénaël E. E. Rabut;Kirsten A. Nagashima;Diep N. H. Tran

  • Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

    Tatjana Dragic;Alexandra Trkola;Steven W. Lin;Kirsten A. Nagashima

  • L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

    Emmanuel G. Cormier;Robert J. Durso;Fotini Tsamis;Lise Boussemart

  • The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

    Tonie Cilliers;Jabulani Nhlapo;Mia Coetzer;Dragana Orlovic

  • Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.

    Emmanuel G. Cormier;Marjan Persuh;Daniah A. D. Thompson;Steven W. Lin

  • Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

    Kristen E. Pascal;Christopher M. Coleman;Alejandro O. Mujica;Vishal Kamat

  • Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

    James M. Binley;Rogier W. Sanders;Rogier W. Sanders;Aditi Master;Charmagne S. Cayanan

  • Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.

    J. M. Orengo;A. R. Radin;V. Kamat;A. Badithe

  • Opportunities for therapeutic antibodies directed at G-protein-coupled receptors

    Catherine J. Hutchings;Markus Koglin;William C. Olson;Fiona H. Marshall

  • HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.

    Meimei Shan;Per Johan Klasse;Kaustuv Banerjee;Antu K Dey

  • Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures

    Audray Harris;Mario J Borgnia;Dan Shi;Alberto Bartesaghi

  • Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

    Jeffrey M. Jacobson;Israel Lowy;Courtney V. Fletcher;Tobias J. O'Neill

Frequent Co-Authors

Paul J. Maddon
Paul J. Maddon Columbia University
John P. Moore
John P. Moore Cornell University
Andrew J. Murphy
Andrew J. Murphy St. Jude Children's Research Hospital
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Peter W. Mason
Peter W. Mason Novartis (Switzerland)
George D. Yancopoulos
George D. Yancopoulos Regeneron (United States)
James M. Binley
James M. Binley Aaron Diamond AIDS Research Center
Thomas J. Ketas
Thomas J. Ketas Cornell University
Brian Zambrowicz
Brian Zambrowicz Regeneron (United States)
Ben Berkhout
Ben Berkhout University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their knowledge beyond microbiology, many related online degrees offer flexible and accessible options. For instance, pursuing one of the online public health masters programs easy to get into can be a great way to specialize in community health and epidemiology, key areas that intersect with microbiology research.

Career paths are diverse for those with a background in biology or health sciences. Becoming a child life specialist offers a unique opportunity to support the well-being of children in medical settings, blending science with compassionate care.

Additionally, individuals looking for educational opportunities regardless of past challenges might explore college degrees for felons. Many programs focus on inclusivity and offer pathways to meaningful careers.

For those interested in practical healthcare applications, functional medicine nurse practitioner programs provide specialized training emphasizing holistic and individualized patient care, a growing field complementary to microbiological sciences.

Best Scientists Citing William C. Olson

Trending Scientists

Recently Published Articles